These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30031716)

  • 21. Transcatheter aortic valve implantation via the superficial femoral artery: An underused access route?
    Saraf S; Cockburn J; Alsanjari O; Hildick-Smith D
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):808-812. PubMed ID: 29481731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified Single-Puncture Technique for Transcatheter Aortic Valve Implantation in Patients without Peripheral Vascular Access.
    Lucchese G; Montarello N; Bapat V
    Thorac Cardiovasc Surg; 2017 Apr; 65(3):231-233. PubMed ID: 27517165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease.
    Alvarez-Covarrubias HA; Joner M; Cassese S; Warmbrunn M; Lutz J; Trenkwalder T; Seguchi M; Aytekin A; Presch A; Pellegrini C; Rheude T; Patrick Mayr N; Kufner S; Schunkert H; Kastrati A; Xhepa E
    Catheter Cardiovasc Interv; 2023 Feb; 101(3):628-638. PubMed ID: 36709496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iliofemoral artery lumen volume assessment with three dimensional multi-detector computed tomography and vascular complication risk in transfemoral transcatheter aortic valve replacement.
    Hammer Y; Landes U; Zusman O; Kornowski R; Witberg G; Orvin K; Levi A; Codner P; Vaknin-Assa H; Nassar M; Shafir G; Assali A; Hamdan A
    J Cardiovasc Comput Tomogr; 2019; 13(1):68-74. PubMed ID: 30340961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a balloon-expandable vascular access system in transfemoral TAVI patients.
    Millán X; Azzalini L; Khan R; Cournoyer D; Dorval JF; Ibrahim R; Bonan R; Asgar AW
    Catheter Cardiovasc Interv; 2016 Dec; 88(7):1145-1152. PubMed ID: 27029571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
    Zaman S; Gooley R; Cheng V; McCormick L; Meredith IT
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):276-84. PubMed ID: 27107395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfemoral transcatheter aortic valve implantation in patients with small diseased peripheral vessels.
    Ruparelia N; Buzzatti N; Romano V; Longoni M; Figini F; Montorfano M; Kawamoto H; Miyazaki T; Spagnolo P; Alfieri O; Colombo A; Latib A
    Cardiovasc Revasc Med; 2015 Sep; 16(6):326-30. PubMed ID: 26104848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter aortic valve replacement through transcaval aortic access in a patient with duplicated inferior vena cava and poor iliofemoral anatomy.
    Fanari Z; Al-Akchar M; Mahmaljy H; Goel S; Goswami NJ
    Cardiovasc Revasc Med; 2017 Dec; 18(8):604-606. PubMed ID: 28774836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of transfemoral versus transapical access on mortality among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Koifman E; Magalhaes M; Kiramijyan S; Escarcega RO; Didier R; Torguson R; Ben-Dor I; Corso P; Shults C; Satler L; Pichard A; Waksman R
    Cardiovasc Revasc Med; 2016; 17(5):318-21. PubMed ID: 27394178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
    Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of large bore access complications in the era of trans-catheter aortic valve replacement.
    Parker MH; Mukherjee D; Ryan L
    Vascular; 2021 Aug; 29(4):610-615. PubMed ID: 33148138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimally invasive versus transapical versus transfemoral aortic valve implantation: A one-to-one-to-one propensity score-matched analysis.
    Furukawa N; Kuss O; Emmel E; Scholtz S; Scholtz W; Fujita B; Ensminger S; Gummert JF; Börgermann J
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1825-1834. PubMed ID: 29861110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent severe aortic stenosis after transfemoral transcatheter valve-in-valve-in-valve replacement.
    Ochiai T; Yoon SH; Sharma R; Chakravarty T; Nakamura M; Cheng W; Makkar R
    J Thorac Cardiovasc Surg; 2018 May; 155(5):e141-e144. PubMed ID: 29422220
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation.
    Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
    Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes mellitus is not associated with worse vascular outcome following percutaneous transfemoral transcatheter aortic valve implantation.
    Lareyre F; Mialhe C; Bourlon F; Habib Y; Dommerc C; Raffort J
    Acta Cardiol; 2019 Dec; 74(6):480-486. PubMed ID: 30642229
    [No Abstract]   [Full Text] [Related]  

  • 37. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoconduit for Transcatheter Aortic Valve Implantation.
    Murakami T; Takahashi Y; Nishimura S; Iwata S; Yamada T; Yoshiyama M; Shibata T
    Ann Thorac Cardiovasc Surg; 2020 Dec; 26(6):365-368. PubMed ID: 29760324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Saleh N; De Palma R; Settergren M; Rück A
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.